NEWS & INSIGHTS
1 June 2023, With the commitment to help improve the health and well-being of people, UITC and AFT Pharmaceuticals enters partnership to expand channel distribution for Maxigesic® AFT Pharmaceuticals is an ASX-listed company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT and UITC will continue to expand the product line to build a healthier life for everyone.
26 May 2023, Following the successful launch of Germidine Sore Throat Spray into the retail segment in March 2022, UITC now expands into the wound care space with Germidine Antiseptic Solution. Germidine provides broad antimicrobial activity and is the antiseptic of choice.
20 February 2023, UITC has been appointed as the exclusive distributor of Pomi-T, a scientifically evaluated polyphenol-rich whole food supplement that has been studied in a UK national scientific study led by oncologist Professor Robert Thomas. Pomi-T positively influenced the rate of PSA progression among men with localised prostate cancer.
11 Jan 2023, UITC is pleased to announce that it has received regulatory approval for K-CAB, a new potassium competitive acid blocker drug indicated for the treatment of erosive gastroesophageal reflux disease (GERD), non-erosive gastroesophageal reflux disease (NERD), gastric ulcer (GU) and eradication of H.pylori when concurrently given with appropriate antibiotic therapy in patients with peptic ulcer and/or chronic atrophic gastritis.
19 Oct 2022, Zambon has appointed UITC as the exclusive distributor of Nasaval, launching the first ever powder nasal spray in Singapore that blocks and deactivates airborne germs and viruses in just 2 minutes. Nasaval Cold & Flu Blocker is one of the many product line up that Nasaval has to offer, providing consumers with the protection that they truly need.